CO60 Comparative Real-World Effectiveness of Tyrosine Kinase Inhibitors as Induction Therapy for Philadelphia-Positive Acute Lymphoblastic Leukemia: A Multicenter Retrospective Study
Year: 2025
Type: article
Language: en
Topic: Acute Lymphoblastic Leukemia research
Authors and affiliations:
raw_author_name: Talha Badar
raw_affiliation_strings: Division of Hematology-Oncology and Bone Marrow Transplant Program, Mayo Clinic, Jacksonville, FL, USA
raw_author_name: Michael Heckman
raw_affiliation_strings: Quantitative Health Sciences, Mayo Clinic, Jacksonville, FL, USA
raw_author_name: Yan Zhang
raw_affiliation_strings: US HEOR, Takeda Pharmaceuticals America, Inc., Lexington, MA, USA
raw_author_name: Sophia Blumenfeld
raw_affiliation_strings: Quantitative Health Science, Mayo Clinic, Jacksonville, FL, USA
raw_author_name: Ravi Narra
raw_affiliation_strings: Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA
raw_author_name: Emily Curran
raw_affiliation_strings: Internal Medicine, Division of Hematology/Oncology, University of Cincinnati Cancer Center, Cincinnati, OH, USA
raw_author_name: Vamsi Kota
raw_affiliation_strings: Hematology and Oncology, Georgia Cancer Center at WellStar MCGHealth, Augusta, GA, USA
raw_author_name: Rory Shallis
raw_affiliation_strings: Section of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA
raw_author_name: Anand Patel
raw_affiliation_strings: Section of Hematology-Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA
raw_author_name: Anjali Advani
raw_affiliation_strings: Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA
raw_author_name: Neil Palmisiano
raw_affiliation_strings: Blood Disorders, Rutgers Cancer Institute, New Brunswick, NJ, USA
raw_author_name: Ehab Atallah
raw_affiliation_strings: Internal Medicine, Medical College of Wisconsin, Milwuakee, WI, USA
raw_author_name: Alice Mims
raw_affiliation_strings: Division of Hematology, The Ohio State University, Columbus, OH, USA
raw_author_name: Alexander Coltoff
raw_affiliation_strings: Medicine, Division of Hematology/Oncology, Medical University of South Carolina, Charleston, SC, USA
raw_author_name: Cameron Hunter
raw_affiliation_strings: Internal Medicine (Hematology), Yale School of Medicine, New Haven, CT, USA
raw_author_name: Shyam A. Patel
raw_affiliation_strings: Division of Hematology/Oncology, UMass Chan Medical School, Worcester, MA, USA
raw_author_name: Adam DuVall
raw_affiliation_strings: Medicine, University of Chicago Medicine, Chicago, IL, USA
raw_author_name: Zulfa Omer
raw_affiliation_strings: Department of internal medicine, division of Hematology and medical oncology, University of Cincinnati, Cincinnati, OH, USA
raw_author_name: Omer Jamy
raw_affiliation_strings: Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
raw_author_name: Brian Jonas
raw_affiliation_strings: Internal Medicine: Malignant Hematology/Cellular Therapy and Transplantation, University of Califonia, Davis, Sacramento, CA, USA
raw_author_name: Charles E. Foucar
raw_affiliation_strings: Internal Medicine, University of New Mexico Comprehensive Cancer Center, Albuquerque, NM, USA
raw_author_name: L. Evan Reddick
raw_affiliation_strings: US Medical Affairs, Takeda Pharmaceuticals Americas, Inc., Lexington, MA, USA
raw_author_name: Luis G. Hernandez
raw_affiliation_strings: Head, Global Health Economics & US HEOR, Takeda Pharmaceuticals America, Inc., Lexington, MA, USA
raw_author_name: Mark Litzow
raw_affiliation_strings: Hematology, Mayo Clinic, Rochester, MN, USA